Marketing of Unproven Stem Cell-Based Interventions: A Call to Action. This new publication provides important evidence on the risks of unproven stem cell thertherpaies
Here is a report handed down by NSW Coroner on the death of a patient with dementia following adipose-treatment at Macquarie Stem Cells:
This report calls for ‘legal protection against the exploitation of severely and chronically ill people by purveyors of scientifically dubious “therapies” and that it is ‘disturbing that he (and presumably others) would market this “experimental” or “innovative” therapy for profit to vulnerable and desperate people in the full knowledge both that there is little scientific support for the “therapy” in relation to dementia and that he is not conducting a clinical trial of any scientific standing or worth. The obvious potential for the providers of such purported remedies and therapies to exploit such consumers is great and therefore troubling. So too is the potential conflict of interest between the principle of harm minimisation and commercial medicine.’
Background Briefing on ABC Radio National featured a story on autologous stem cell treatment in Australia.